Hutch News

Hutch News

Stories tagged 'Vaccine development - Viral cancers'

Highlights of Fred Hutch science in 2018

A look back at notable advances in immunotherapy, precision screening and more

Dec. 18, 2018 | By Fred Hutch News Service staff

From basic biology to survivors’ pocketbooks, our researchers explore every angle of cancer. Here are just a few of the strides our teams made in 2018.

View story >


5 questions on dengue vaccine analysis

Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines

June 20, 2018 | By Mary Engel / Fred Hutch News Service

Asked to help re-examine clinical trials data, Fred Hutch biostatisticians foresee a new era of personalized vaccines

View story >


The pride of Fred Hutch

HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade

June 7, 2018 | By Mary Engel / Fred Hutch News Service

During Pride Month, a parade of honors is in store for HIV Vaccine Trials Network veteran Steven Wakefield, external relations director for the Fred Hutch–based global group.

View story >


A focus on partnerships at Hutch/Merck summit

Research on the immune system aims to stop infectious diseases and cancer

May 11, 2018 | By Sabin Russell / Fred Hutch News Service

Article about a daylong Infectious Disease Summit hosted by Fred Hutch May 10 in Seattle.

View story >


First human antibody found to block Epstein-Barr virus

Early research could open new path for vaccine against EBV-related cancers, mononucleosis

April 17, 2018 | By Mary Engel / Fred Hutch News Service

The finding opens a new path to developing a vaccine against EBV, a virus best known for causing mono but which is associated with about 200,000 cancer cases a year.

View story >


New antibody and unique binding site offer possible paths to malaria prevention

Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design

March 19, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.